The Patent Finder

Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors

AMD (U.S.) Holdings, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,709,702Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors
In force
 · High confidence
UsedRemaining
AMD Therapeutics LLCIn forceHigh confidence
Application 16/912,058Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors
Abandoned
Abandoned Feb 24, 2022
AMD Therapeutics LLCAbandonedAbandoned Feb 24, 2022
Application 17/674,648Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors
Pending
Not granted
AMD Therapeutics LLCPendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by AMD (U.S.) Holdings, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited